What makes the bacteria behind Lyme disease tick?

February 8, 2018, University of Connecticut
UConn Health researchers led by postdoctoral fellow Ashley Groshong, shown here in UConn Health's Spirochete Research Lab, are advancing understanding of how the bacteria Borrelia burgdorferi transmits Lyme disease, pointing to the potential for ultimately developing therapeutics to target this system. Credit: Office of the Vice President for Research Photo

Connecticut residents are all too familiar with Lyme disease, but the precise mechanisms of how humans become infected are still unclear. Researchers from UConn Health are advancing the understanding of how the causative bacterial agent of Lyme disease, Borrelia burgdorferi (Bb), survives in ticks and mammals.

The findings from Ashley Groshong, a postdoctoral fellow in the Spirochete Research Lab at UConn Health, and her colleagues were recently published in mBio.

Here's a refresher on the typical steps involved in the spreading of Lyme disease.

An infected black-legged tick (Ixodes scapularis) feeds on and infects a mammal, like a white-footed mouse, to transmit a pathogen (i.e. Borrelia burgdorferi) to its next mammalian host. While the tick may prefer to feed from small rodents or deer, oftentimes humans are an accidental host. In this case, transmission of the bacteria to humans results in disease pathology.

This bacterial pathogen is a spirochete, which means it has a unique spiral shape, and it is slow to replicate. It also depends entirely on its host for nutrients, a unique characteristic that has drawn attention from many Lyme researchers. While previous genetic analyses have suggested that the Bb's genome encodes a cellular transport system capable of importing nutrients from the host in the form of peptides, the importance of the system for viability and pathogenesis had never been established.

"We wanted to target the energy domain of the system to understand exactly how important this system is for survival and proliferation during infection," explains Groshong. "If we understand how B. burgdorferi acquires its nutrients from its hosts and which nutrients are essential, it could potentially lead to a novel target for therapeutic intervention."

The peptide transport system is quite complex, preventing previous evaluation of its role in the bacteria. To better understand the importance of peptides, a source of amino acids, Groshong and the UConn Health team adopted a novel approach. Groshong created a mutant version of B. burgdorferi that effectively blocks the spirochete's normal methods of consuming peptides by targeting the lynchpin of the transporter, the part of the system that provides energy for peptide transport.

The research showed that spirochetes deprived of peptides failed to replicate, which indicates that peptide uptake is essential for bacterial viability and ability to infect. In other words, Groshong and the UConn Health team have shown that if Bb's transport system is inhibited, it would be possible to block the proliferation of the bacteria in an infected mammal, such as a human or rodent. Interestingly, this is the only pathogen demonstrated to require for basic viability, making this a unique find in the world of pathogenic bacteria.

Lyme disease research is particularly important for Connecticut residents, where the condition was first recognized in Lyme, Connecticut, in 1975. According to the Connecticut State Department of Public Health, approximately 30,000 people in the state are diagnosed with Lyme disease each year.

"When it comes to helping Connecticut tackle Lyme disease, UConn is providing support on all fronts," says Radenka Maric, vice president for research at UConn and UConn Health, "from tick testing at the Connecticut Veterinary Medical Diagnostic Laboratory to innovative research like Dr. Groshong's at the Spirochete Research Lab. UConn's faculty, postdoctoral fellows, and students are conducting research to find solutions to the major health challenges we face today."

Groshong plans to build on this research through a project that will explore possible ways to target this system for the development of therapeutics and to evaluate if a limited peptide environment, such as the mammal, promotes the formation of antibiotic-tolerant persister cells. This research will be funded through a Blackman Fellowship from the Global Lyme Alliance.

According to Groshong, there is still a long way to go before this research could translate into a new treatment option, but she's hopeful about what this discovery means for the study of Lyme disease.

"Right now, our options for treating and preventing this infection are limited and not specific to the bacteria," says Groshong. "Our goal is to conduct research that could lead to better understanding of how these bacteria cause , as well as novel and targeted approaches to new therapies."

Explore further: Lone star ticks not guilty in spread of Lyme disease

More information: Ashley M. Groshong et al. Peptide Uptake Is Essential for Borrelia burgdorferi Viability and Involves Structural and Regulatory Complexity of its Oligopeptide Transporter, mBio (2018). DOI: 10.1128/mBio.02047-17

Related Stories

Lone star ticks not guilty in spread of Lyme disease

January 31, 2018
Not all ticks are alike—particularly when it comes to their role in spreading Lyme disease.

How a tick gut gene serves as a gateway for Lyme disease

August 7, 2017
The bacterium that causes Lyme disease, Borrelia burgdorferi, may have some help from a gene found in the guts of infected ticks, according to a new study led by Yale researchers and published in Nature Communications.

Key to Lyme disease's locale may be found in the gut of a tick

January 16, 2014
The prevalence of Lyme disease varies greatly between different locales throughout the Northeast, even though the deer ticks that transmit Lyme bacterium are common throughout the entire region.

Ticks that vector Lyme disease move west into North Dakota

September 11, 2014
According to the U.S. Centers for Disease Control, there are more than 300,000 cases of Lyme disease in the U.S. each year. Last year, most Lyme disease cases reported to the CDC were concentrated heavily in the Northeast ...

Lyme disease 'Biofilm' eludes antibiotics: report

February 25, 2016
(HealthDay)—The bacteria that causes Lyme disease protects itself from antibiotics by forming a slime-like layer called a biofilm, a new study shows.

Lyme bacteria survive 28-day course of antibiotics months after infection

December 13, 2017
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of two papers published in the peer-reviewed journals PLOS ONE and American Journal of Pathology, that seem to support ...

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.